Medication Quick Facts
📋Overview
Reyvow is a serotonin (5-HT) 1F receptor agonist that targets specific pathways in the central nervous system. It is designed to stop a migraine attack after it has already begun by interacting with receptors involved in pain signaling.
This medication is used to manage the pain and symptoms associated with active migraine episodes. It is classified as an acute treatment and is not intended for the long-term prevention of migraine attacks.
🛡️ Educational information only
This content is provided for general health education and awareness and is based on publicly available medical information. It is not intended to replace professional medical advice, diagnosis, or treatment, and should not be used to make healthcare decisions. Always seek the guidance of a qualified healthcare professional regarding any medical condition, medication, supplement, or procedure.
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
